文献速递乳腺外科围术期管理与 ERAS

乳腺癌大手术后并发症与生存的瑞典人群研究

Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women.
PubMed 文献 · Br J Surg · 2022-01-01

中位随访6.22年,调整混杂后大并发症仍与更差的总生存(HR 1.32)和乳腺癌特异性生存(HR 1.31)相关,仅在无重建乳房切除者中显著。

要点

  • 大手术并发症与更差的总生存和乳腺癌特异性生存独立相关。
  • 该关联仅在无重建的乳房切除患者中保持显著。
  • 结果支持在乳腺癌手术中推进手术降阶梯。

核心结论

  • 大手术术后并发症与更差的生存相关,尤其在乳房切除术后。
  • 结果强调手术降阶梯的重要性。

研究设计与样本

  • 基于瑞典全国前瞻性登记数据的 population-based 队列研究。
  • 仅考虑30天内导致再入院和/或再手术的大手术术后并发症。
  • 主要结局为总生存(OS)和乳腺癌特异性生存(BCSS),采用多因素Cox模型调整临床、社会经济混杂因素和合并症。

主要发现

  • 共9163例死亡,其中3472例死于乳腺癌。
  • 大手术并发症在乳房切除伴或不伴即刻重建后更常见(分别为7.3%和4.3%),高于保乳手术(2.3%)。
  • 有大并发症者未调整5年OS为82.6%(95%CI 80.8-84.5),BCSS为92.1%(90.8-93.5);无并发症者分别为88.8%(88.6-89.1)和95.0%(94.8-95.2)(P<0.001)。
  • 调整后大并发症仍与更高的全因死亡(OS:HR 1.32,95%CI 1.15-1.51)和乳腺癌死亡(BCSS:HR 1.31,1.04-1.65)相关;分层后仅在无重建乳房切除者中显著(OS:HR 1.41,1.20-1.66;BCSS:HR 1.36,1.03-1.79)。

临床怎么用

  • 在乳腺癌手术决策中应重视避免大手术并发症,尤其对接受乳房切除的患者。
  • 支持在合适患者中优先考虑手术降阶梯(如保乳手术)以减少并发症及其对生存的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative complications may activate prometastatic systemic pathways through tissue damage, wound healing, infection, and inflammation. Postoperative complications are associated with inferior survival in several types of cancer. The aim was to determine the association between postoperative complications and survival in breast cancer. METHODS: This population-based cohort included women operated for T1-3 N0-3 M0 invasive breast cancer in Sweden from 2008 to 2017. Only major surgical postoperative complications leading to readmission and/or reoperation within 30 days were considered. Main outcomes were overall survival (OS) and breast cancer-specific survival (BCSS). Prospectively collected nationwide register data were used. Multivariable Cox models were adjusted for clinical and socioeconomic confounders and co-morbidity. RESULTS: Among 57 152 women, major surgical postoperative complications were registered for 1854 patients. Median follow-up was 6.22 (0.09-11.70) years. Overall, 9163 patients died, and 3472 died from breast cancer. Major surgical postoperative complications were more common after mastectomy with or without immediate reconstruction (7.3 and 4.3 per cent respectively) than after breast-conserving surgery (2.3 per cent). Unadjusted 5-year OS and BCSS rates were 82.6 (95 per cent c.i. 80.8 to 84.5) and 92.1 (90.8 to 93.5) per cent respectively for women with a major surgical postoperative complication, and 88.8 (88.6 to 89.1) and 95.0 (94.8 to 95.2) per cent for those without a complication (P < 0.001). After adjustment, all-cause and breast cancer mortality rates remained higher after a major surgical postoperative complication (OS: HR 1.32, 95 per cent c.i. 1.15 to 1.51; BCSS: HR 1.31, 1.04 to 1.65). After stratification for type of breast surgery, this association remained significant only for women who had mastectomy without reconstruction (OS: HR 1.41, 1.20 to 1.66; BCSS: HR 1.36, 1.03 to 1.79). CONCLUSION: Major surgical postoperative complications are associated with inferior survival, especially after mastectomy. These results underline the importance of surgical de-escalation.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. de Boniface J, Szulkin R, Johansson ALV, et al. Major surgical postoperative complications and survival in breast cancer: Swedish population-based register study in 57 152 women. Br J Surg. 2022. PMID: 35929050. doi:10.1093/bjs/znac275

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。